Phosphagenics reports positive results of TPM additive in poultry feed
Drug delivery company Phosphagenics (ASX: POH) has reported the successful outcome of its second study into using its TPM drug delivery system to combat stress conditions in poultry.
According to the company, its second poultry study has confirmed the optimum TPM dose to reduce the negative impact of environmental stress, particularly heat, in birds.
Feed additives are included in the birds’ feed to boost growth, laying capacity, prevent diseases and enhance feed use.
The study was undertaken in an Australian-based research facility to investigate adding TPM to broilers’ feed and its impact on growth during heat stress. The study also looked into possible additional benefits from including TPM in the feed.
Study results backed previous research findings, demonstrating that 10 parts per million of TPM in poultry feed improved performance and negated the negative impact heat stress has on growth.
“We have seen in the past that TPM can improve broiler performance under normal conditions, but to see the relative normalisation of performance under heat stress was impressive and provides further insight on the application and use of TPM as a feed additive in the market,” Phosphagenics general manager of animal health and nutrition Dr Roksan Libinaki said.
“We are very keen to see the work being published with the research team in the new year,” Dr Libinaki added.
In addition to testing TPM in poultry, Phosphagenics has investigated TPM’s effectiveness in pigs and a trial is nearing completion on its use in cattle.
Phosphagenics chief executive officer Dr Ross Murdoch said the company had “demonstrated significant utility and value for TPM in both the pig and poultry feed sector”.
“Discussions with key potential partners have highlighted poultry as a key species of interest, increasing the importance of this result,” Mr Murdoch said.
Phosphagenics claims the global poultry feed market is worth more than A$180 billion and this is predicted to hit A$220 billion by 2020.
The company’s stock soared more than 18% in early morning trade to sit at A$0.019.